Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 3:22 pm Sale |
2021-02-10 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
BML Investment Partners, L.P. | 140,663 4.500% |
-12,019 (-7.87%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
The Vanguard Group | 180,772 5.760% |
180,772 (New Position) |
Filing History |
| 2021-01-08 9:59 pm Purchase |
2020-09-18 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
Ikarian Capital LLC | 31,719 1.000% |
31,719 (New Position) |
Filing History |
| 2020-11-20 5:31 pm Unchanged |
2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
Satter Muneer A | 374,789 11.900% |
0 (Unchanged) |
Filing History |
| 2020-11-12 5:15 pm Purchase |
2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
ORBIMED ADVISORS LLC | 346,263 11.000% |
346,263 (New Position) |
Filing History |
| 2020-05-15 06:05 am Sale |
2020-05-13 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
Novartis Bioventures Ltd | 42,349 1.570% |
-167,495 (-79.82%) |
Filing History |